Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03604380 · ClinicalTrials.gov registry record · NA

STATE Trial: SusTained Attention Training to Enhance Sleep - Remote

A NA study, sponsored by Posit Science Corporation.

Completed
Registry status
NA
Development phase
134
Enrollment target

NCT03604380: Completed NA study, sponsored by Posit Science Corporation.

NCT03604380 is a NA study that has completed, run by Posit Science Corporation. The registered enrollment target is 134 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03604380, a NA study, has completed, sponsored by Posit Science Corporation.

COMPLETED
Registry status
NA
Development phase
134 participants
Enrollment target

Study Summary

This study is a validation study to document the acceptability of the Tonic and Phasic Alertness Training (TAPAT) program in older adults with chronic late-life insomnia. The goal of this study is to employ a computerized attention-training program, TAPAT, designed for chronic late-life insomnia in a remote, randomized, controlled trial to assess feasibility and initial efficacy in this population.

Interventions

  • OTHER Active Comparator
  • OTHER Computerized Plasticity-Based Adaptive Cognitive Training

Trial Details

FieldValue
Enrollment Target 134 participants
Start Date 2018-07-10
Est. Completion 2020-11-04
Phase NA
Posit Science Corporation

30 total trials

What the finished NCT03604380 record still lists

NCT03604380 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which Active Comparator is the first listed.

NCT03604380 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03604380 about?

NCT03604380 is a clinical study titled "STATE Trial: SusTained Attention Training to Enhance Sleep - Remote". This study is a validation study to document the acceptability of the Tonic and Phasic Alertness Training (TAPAT) program in older adults with chronic late-life insomnia. The goal of this study is to employ a computerized attention-training program, TAPAT, designed for chronic late-life insomnia in ...

What is the current status of trial NCT03604380?

This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2018-07-10. Estimated completion is 2020-11-04.

What interventions are being tested in trial NCT03604380?

The interventions under investigation include: Active Comparator (OTHER), Computerized Plasticity-Based Adaptive Cognitive Training (OTHER).

Who is sponsoring clinical trial NCT03604380?

This trial is sponsored by Posit Science Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03604380's enrollment target sits among peer trials

134 728th of 2000 higher than 1,272 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02469662 · 134 participants · NA

    Clinical Outcomes Study of the Nexel Total Elbow

  • NCT03110822 · 134 participants · Phase 1

    A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

  • NCT04678648 · 134 participants · Phase 1

    A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

  • NCT05264857 · 134 participants · NA

    Decision Aid and Thyroid Nodules Management

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03604380, the US trial registry maintained by the National Library of Medicine. NCT03604380 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.